Eko Foundation Analysis Software with Transformers (EFAST) vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EFAST is designed for real-time, auscultation-based screening for structural murmurs and atrial fibrillation during routine physical exams. EchoGo Amyloidosis, conversely, specializes in analyzing echocardiogram video clips for the early detection of cardiac amyloidosis. They serve different diagnostic needs within cardiology, utilizing distinct data inputs and targeting different conditions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams. It is intended for use on both pediatric and adult patients for murmur detection, and adults over 18 for AFib detection. EchoGo Amyloidosis by Ultromics is an AI-powered screening tool that analyzes echocardiogram video clips to aid in the early detection of cardiac amyloidosis, primarily for identifying patients at risk from an echocardiogram.
EFAST integrates seamlessly with Eko digital stethoscopes, providing real-time AI analysis during auscultation and offers EMR integration for streamlined documentation. EchoGo Amyloidosis analyzes echocardiogram video clips and integrates with existing clinical workflows and IT infrastructure such as PACS, DICOM, and HL7.
EFAST reports 93% sensitivity and 91% specificity for structural murmur detection, and 95% sensitivity and 94% specificity for atrial fibrillation detection. EchoGo Amyloidosis demonstrates high diagnostic accuracy for cardiac amyloidosis with 85% sensitivity and 93% specificity, performing consistently across CA subtypes.
EFAST is designed for use across Cardiology, Family Medicine, and Internal Medicine, enabling smarter cardiac care during routine exams. EchoGo Amyloidosis is primarily specialized for Cardiology, aiding in the early detection of cardiac amyloidosis from echocardiograms.
More Comparisons
Backers
Who funded each tool's parent company.